Co-Diagnostics (NASDAQ:CODX) Inc said it has partnered with TiiCKER—a consumer shareholder loyalty platform—to increase its connection to retail investors.
The Salt Lake City-based company has teamed up with TiiCKER to reach new and existing investors, verify its shareholders and stock perks, and connect with retail investors interested in learning more about its world-class testing services and technology.
READ: Co-diagnostics JV CoSara receives clearance from Indian regulators for ABC Multiplex Test
"We have a great technology and growth story to tell, but it was previously impossible for us to reach retail investors let alone verify their ownership to engage shareholders and reward their loyalty," said Dwight Egan, Co-Diagnostics (NASDAQ:CODX)' CEO. "With the TiiCKER platform and app, we can now connect with retail investors directly, grow our awareness among this long-term and loyal audience, and show them how much we appreciate their support."
TiiCKER has created a new industry— direct-to-shareholder marketing— by partnering with innovative public companies and major brands to build and grow the first shareholder loyalty and engagement platform.
"Retail investors are looking to discover new ideas and compelling stocks, and shareholders, like everyday consumers, want to be rewarded for their loyalty," said Jeff Lambert, CEO of TiiCKER.
He added: "Co-Diagnostics rightly values this investor audience and its scale— 130 million individual investors in the U.S. alone —as an untapped audience as it looks to grow the CODX profile to match its track record of performance. Likewise, their B2B business model, but highly relevant technology helping people in over 50 countries battle disease and diagnosis genetic markers is an ideal fit for TiiCKER and our ability to reach retail investors."
Co-Diagnostics is a molecular diagnostics company that develops, manufactures, and markets diagnostics technology. The company's technology is utilized for tests that are designed using the detection and analysis of nucleic acid molecules (DNA or RNA).
Contact Ritika at ritika@proactiveinvestors.com